Literature DB >> 11884395

Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways.

Yi Zhang1, Wen-Jie Qiu, Siu Chiu Chan, Jiahuai Han, Xi He, Sheng-Cai Lin.   

Abstract

Axin uses different combinations of functional domains in down-regulation of the Wnt pathway and activation of the MEKK1/JNK pathway. We are interested in the elucidation of the functional switch of Axin. In the present study, we show that the Wnt activator CKIepsilon, but not CKIIalpha, Frat1, LRP5, or LRP6, inhibited Axin-mediated JNK activation. We also found that both CKIalpha and CKIepsilon interacted with Axin, whereas CKIIalpha did not bind to Axin and had no effect on Axin-mediated JNK activity even though CKIIalpha has also been suggested to be an activator for the Wnt pathway. The COOH-terminal region and the MEKK1-interacting domain of Axin are important for CKIalpha-Axin and CKIepsilon-Axin interaction. We further demonstrated that CKIepsilon and CKIalpha binding to Axin excluded MEKK1 binding, indicating that a competitive physical occupancy may underlie the inhibitory effect. Moreover, our data indicated that CKIepsilon kinase activity plays an additive role in this effect. Taken together, we have demonstrated that CKI and CKII exhibit differential effects on Axin-MEKK1 interaction and Axin-mediated JNK activation. Furthermore, our data suggest that CKI may provide a possible switch mechanism for Axin function in the regulation of Wnt and JNK pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884395     DOI: 10.1074/jbc.M111982200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6.

Authors:  Joshua Wolf; Todd R Palmby; Julie Gavard; Bart O Williams; J Silvio Gutkind
Journal:  FEBS Lett       Date:  2007-12-18       Impact factor: 4.124

2.  Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays.

Authors:  Jakub Harnoš; Jan Ryneš; Pavlína Víšková; Silvie Foldynová-Trantírková; Lola Bajard-Ešner; Lukáš Trantírek; Vítězslav Bryja
Journal:  J Biol Chem       Date:  2018-08-30       Impact factor: 5.157

Review 3.  Diversity of axin in signaling pathways and its relation to colorectal cancer.

Authors:  Nighat Parveen; Mahboob Ul Hussain; Arshad A Pandith; Syed Mudassar
Journal:  Med Oncol       Date:  2010-10-30       Impact factor: 3.064

Review 4.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

5.  Potential of casein kinase I in digestive cancer screening.

Authors:  Cristina Modak; Jianyuan Chai
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

Review 6.  Dancing Protein Clouds: The Strange Biology and Chaotic Physics of Intrinsically Disordered Proteins.

Authors:  Vladimir N Uversky
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

7.  Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6.

Authors:  Michelle Carter; Xu Chen; Bozena Slowinska; Sharon Minnerath; Sara Glickstein; Lei Shi; Fabien Campagne; Harel Weinstein; M Elizabeth Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-26       Impact factor: 11.205

8.  Stochastic machines as a colocalization mechanism for scaffold protein function.

Authors:  Bin Xue; Pedro R Romero; Maria Noutsou; Madelon M Maurice; Stefan G D Rüdiger; Albert M William; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky; A Keith Dunker
Journal:  FEBS Lett       Date:  2013-04-18       Impact factor: 4.124

9.  FADD phosphorylation is critical for cell cycle regulation in breast cancer cells.

Authors:  S Matsuyoshi; K Shimada; M Nakamura; E Ishida; N Konishi
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

Review 10.  Molecular regulation and pharmacological targeting of the β-catenin destruction complex.

Authors:  Eline C van Kappel; Madelon M Maurice
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.